Marijuana grown by the University of Mississippi for clinical research purposes shared genetics typically associated with industrial hemp, not commercially available cannabis, according to an analysis prepared by researchers at the University of Northern Colorado.
A separate study published in 2017 reported that U-Miss samples contain far lower levels of both THC and CBD than do commercially available cannabis. Clinicians wishing to conduct FDA-approved clinical trials on cannabis have long complained that federally-provided samples are of inferior quality.
According to the program’s current marijuana menu, no available samples contain more than seven percent THC and all samples contain less than one percent CBD.
